The Frankfurt Institute of Clinical Cancer Research
We are a globally acting clinical research institution specializing in investigator-initiated and industry-academia collaborative clinical cancer research.
Founded by oncologists driven by a shared vision to make a global impact, our mission is to advance science-driven cancer research through collaboration between industry and academia.
By leveraging the strengths and expertise of both sectors we strive to conduct transformative research and provide answers to crucial clinical questions.
Our research activities have a clear objective: to conduct and facilitate excellent clinical cancer research at the international level in order to improve the treatment and quality of life of cancer patients.
Our research activities have a clear objective: to conduct and facilitate excellent clinical cancer research at the international level in order to improve the treatment and quality of life of cancer patients.
Through our Comprehensive Research Organization service (CRO), our work covers all areas of clinical cancer research at the highest level.
Through our Comprehensive Research Organization service (CRO), our work covers all areas of clinical cancer research at the highest level.
Our team of physicians, who have years of expertise and current knowledge in medical care, are specialized in the fields of hematology, oncology, surgical oncology, palliative medicine, supportive therapy, and human genetics. Our founders are oncologists, and this expertise is a hallmark of IKF.
With well-established networks of almost hundreds of medical institutions, the best experts in their respective fields for every disease type, and the largest academic study groups in Germany and Europe, IKF has a powerful network that sets us apart.
IKF provides well-established access to routine clinical oncology environments through long-term collaborations with university hospitals, other large hospitals, and private oncology practitioners.
Our interactive and comprehensive molecular profiling network, PLATON, provides a unique opportunity to screen a sufficient number of patients with distinct genetic alterations/mutations for biomarker-based clinical trials.
Our team of physicians, who have years of expertise and current knowledge in medical care, are specialized in the fields of hematology, oncology, surgical oncology, palliative medicine, supportive therapy, and human genetics. Our founders are oncologists, and this expertise is a hallmark of IKF.
With well-established networks of almost hundreds of medical institutions, the best experts in their respective fields for every disease type, and the largest academic study groups in Germany and Europe, IKF has a powerful network that sets us apart.
IKF provides well-established access to routine clinical oncology environments through long-term collaborations with university hospitals, other large hospitals, and private oncology practitioners.
Our interactive and comprehensive molecular profiling network, PLATON, provides a unique opportunity to screen a sufficient number of patients with distinct genetic alterations/mutations for biomarker-based clinical trials.